POINT Biopharma Global Inc. Quarterly Depreciation in USD from Q1 2021 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
POINT Biopharma Global Inc. quarterly/annual Depreciation history and growth rate from Q1 2021 to Q1 2023.
  • POINT Biopharma Global Inc. Depreciation for the quarter ending March 31, 2023 was $538K, a 140% increase year-over-year.
  • POINT Biopharma Global Inc. annual Depreciation for 2022 was $1.4M.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $538K +$313K +140% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q1 2022 $224K +$224K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q1 2021 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.